• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

需要住院治疗的糖尿病足感染患者中耐甲氧西林金黄色葡萄球菌和产超广谱β-内酰胺酶肠杆菌科的危险因素。

Risk factors for methicillin-resistant Staphylococcus aureus and extended-spectrum ß-lactamase producing Enterobacterales in patients with diabetic foot infections requiring hospital admission.

机构信息

Joaquín Gómez Gómez, Hospital Clínico Universitario Virgen de la Arrixaca, Ctra. Madrid-Cartagena s/n, 30120, El Palmar, Murcia, Spain.

José Barberán, Hospital Universitario HM Montepríncipe, Avda. Montepríncipe 25, 28660 Boadilla del Monte, Madrid, Spain.

出版信息

Rev Esp Quimioter. 2020 Dec;33(6):430-435. doi: 10.37201/req/101.2020. Epub 2020 Nov 27.

DOI:10.37201/req/101.2020
PMID:33246358
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7712337/
Abstract

OBJECTIVE

Methicillin-resistant Staphylococcus aureus (MRSA) and extended-spectrum β-lactamase-producing Enterobacterales (ESBL-E) may complicate the treatment of diabetic foot infections (DFIs). The aim of this study was to determine the risk factors for these pathogens in DFIs.

METHODS

This was a prospective observational study of 167 consecutive adult patients with DFIs. The diagnosis and severity of DFIs were based on the Infectious Disease Society of America (IDSA) classification system. Multivariate analyses were performed in order to identify risk factors for MRSA and ESBL-E infections.

RESULTS

S. aureus was the most isolated pathogen (n=82, 37.9 %) followed by Escherichia coli (n= 40, 18.5%). MRSA accounted for 57.3% of all S. aureus and 70% of Klebsiella pneumoniae and 25% of E. coli were ESBL producers, respectively. Deep ulcer [OR 8,563; 95% CI (1,068-4,727)], previous use of fluoroquinolones [OR 2,78; 95% CI (1,156-6,685)] and peripheral vasculopathy [OR 2,47; 95% CI (1.068-4.727)] were the independent predictors for MRSA infections; and osteomyelitis [OR 6,351; 95% CI (1,609-25,068)] and previous use of cephalosporins [OR 5,824; 95% CI (1,517-22,361)] for ESBL-E infections.

CONCLUSIONS

MRSA and ESBL-E have adquired a great clinical relevance in DFIs. The availability of their risk factors is very convenient to choose the empirical treatment in severe forms.

摘要

目的

耐甲氧西林金黄色葡萄球菌(MRSA)和产超广谱β-内酰胺酶肠杆菌科(ESBL-E)可使糖尿病足感染(DFIs)的治疗复杂化。本研究旨在确定 DFIs 中这些病原体的危险因素。

方法

这是一项对 167 例连续成年 DFI 患者的前瞻性观察性研究。DFIs 的诊断和严重程度基于美国传染病学会(IDSA)分类系统。进行了多变量分析以确定 MRSA 和 ESBL-E 感染的危险因素。

结果

金黄色葡萄球菌是最常见的分离病原体(n=82,37.9%),其次是大肠杆菌(n=40,18.5%)。MRSA 占所有金黄色葡萄球菌的 57.3%,肺炎克雷伯菌的 70%和 25%的大肠杆菌为 ESBL 产生菌。深部溃疡[OR 8.563;95%CI(1.068-4.727)]、氟喹诺酮类药物的既往使用[OR 2.78;95%CI(1.156-6.685)]和周围血管病[OR 2.47;95%CI(1.068-4.727)]是 MRSA 感染的独立预测因子;骨髓炎[OR 6.351;95%CI(1.609-25.068)]和头孢菌素类药物的既往使用[OR 5.824;95%CI(1.517-22.361)]是 ESBL-E 感染的独立预测因子。

结论

MRSA 和 ESBL-E 在 DFIs 中具有重要的临床相关性。这些危险因素的存在非常方便选择严重形式的经验性治疗。

相似文献

1
Risk factors for methicillin-resistant Staphylococcus aureus and extended-spectrum ß-lactamase producing Enterobacterales in patients with diabetic foot infections requiring hospital admission.需要住院治疗的糖尿病足感染患者中耐甲氧西林金黄色葡萄球菌和产超广谱β-内酰胺酶肠杆菌科的危险因素。
Rev Esp Quimioter. 2020 Dec;33(6):430-435. doi: 10.37201/req/101.2020. Epub 2020 Nov 27.
2
Co-infection of methicillin-resistant Staphylococcus epidermidis, methicillin-resistant Staphylococcus aureus and extended spectrum β-lactamase producing Escherichia coli in bovine mastitis--three cases reported from India.耐甲氧西林表皮葡萄球菌、耐甲氧西林金黄色葡萄球菌和产超广谱β-内酰胺酶大肠杆菌共感染引起的牛乳腺炎——印度报告的三例病例
Vet Q. 2015 Mar;35(1):56-61. doi: 10.1080/01652176.2014.984365. Epub 2014 Dec 2.
3
Microbiological Pattern, Antimicrobial Resistance and Prevalence of MDR/XDR Organisms in Patients With Diabetic Foot Infection in an Indian Tertiary Care Hospital.印度一家三级护理医院糖尿病足感染患者的微生物模式、抗菌药物耐药性和 MDR/XDR 生物体流行情况。
Int J Low Extrem Wounds. 2023 Dec;22(4):695-703. doi: 10.1177/15347346211038090. Epub 2021 Aug 12.
4
Sulopenem: An Intravenous and Oral Penem for the Treatment of Urinary Tract Infections Due to Multidrug-Resistant Bacteria.舒巴坦钠:一种用于治疗多重耐药菌引起的尿路感染的静脉注射和口服青霉素类药物。
Drugs. 2022 Apr;82(5):533-557. doi: 10.1007/s40265-022-01688-1. Epub 2022 Mar 16.
5
Prevalence of methicillin resistant , multidrug resistant and extended spectrum β-lactamase producing gram negative bacilli causing wound infections at a tertiary care hospital of Nepal.尼泊尔一家三级护理医院伤口感染的耐甲氧西林、多药耐药和产超广谱 β-内酰胺酶革兰氏阴性杆菌的流行情况。
Antimicrob Resist Infect Control. 2018 Oct 8;7:121. doi: 10.1186/s13756-018-0408-z. eCollection 2018.
6
Emergency (clonal spread) of methicillin-resistant Staphylococcus aureus (MRSA), extended spectrum (ESBL)--and AmpC beta-lactamase-producing Gram-negative bacteria infections at Pediatric Department, Bosnia and Herzegovina.波斯尼亚和黑塞哥维那儿科部门耐甲氧西林金黄色葡萄球菌(MRSA)、产超广谱(ESBL)和AmpCβ-内酰胺酶革兰氏阴性菌感染的紧急情况(克隆传播)
Wien Klin Wochenschr. 2014 Dec;126(23-24):747-56. doi: 10.1007/s00508-014-0597-2. Epub 2014 Sep 6.
7
Prevalence of S. aureus and/or MRSA in hospitalized patients with diabetic foot and establishment of LAMP methods for rapid detection of the SCCmec gene.糖尿病足住院患者中金黄色葡萄球菌和/或耐甲氧西林金黄色葡萄球菌的患病率及用于快速检测SCCmec基因的环介导等温扩增方法的建立
BMC Microbiol. 2024 Jan 26;24(1):36. doi: 10.1186/s12866-024-03196-6.
8
Impact of colonization pressure on acquisition of extended-spectrum β-lactamase-producing Enterobacterales and meticillin-resistant Staphylococcus aureus in two intensive care units: a 19-year retrospective surveillance.定植压力对 2 个重症监护病房获得产超广谱β-内酰胺酶肠杆菌科和耐甲氧西林金黄色葡萄球菌的影响:19 年回顾性监测。
J Hosp Infect. 2020 May;105(1):10-16. doi: 10.1016/j.jhin.2020.02.012. Epub 2020 Feb 22.
9
Prevalence of methicillin-sensitive, methicillin-resistant , and extended-spectrum beta-lactamase-producing in newborns: a cross-sectional study.耐甲氧西林敏感、耐甲氧西林和产超广谱β-内酰胺酶 在新生儿中的流行情况:一项横断面研究。
J Matern Fetal Neonatal Med. 2022 Nov;35(22):4243-4249. doi: 10.1080/14767058.2020.1849100. Epub 2020 Nov 18.
10
Epidemiology of Methicillin-Resistant Staphylococcus aureus Diabetic Foot Infections in a Large Academic Hospital: Implications for Antimicrobial Stewardship.大型学术医院耐甲氧西林金黄色葡萄球菌糖尿病足感染的流行病学:对抗菌药物管理的启示
PLoS One. 2016 Aug 24;11(8):e0161658. doi: 10.1371/journal.pone.0161658. eCollection 2016.

引用本文的文献

1
Joint surveillance and correlation analysis of antimicrobial resistance and consumption of seven targeted bacteria, 2017-2023.2017 - 2023年七种目标细菌的耐药性与消耗量联合监测及相关性分析
Sci Rep. 2025 Aug 26;15(1):31381. doi: 10.1038/s41598-025-16957-8.
2
Multidrug resistance, biofilm formation, and genetic determinants in diabetic foot infections from Uttar Pradesh, India: a clinical-microbiological insight from a prospective study.印度北方邦糖尿病足感染中的多重耐药性、生物膜形成及遗传决定因素:一项前瞻性研究的临床微生物学见解
Naunyn Schmiedebergs Arch Pharmacol. 2025 May 23. doi: 10.1007/s00210-025-04284-8.
3
Distribution of multidrug-resistant bacterial infections in diabetic foot ulcers and risk factors for drug resistance: a retrospective analysis.糖尿病足溃疡患者中多重耐药菌感染的分布及耐药危险因素分析:一项回顾性研究
PeerJ. 2023 Oct 9;11:e16162. doi: 10.7717/peerj.16162. eCollection 2023.
4
Important aspects during management of diabetic foot infection.糖尿病足感染管理的重要方面。
Rev Esp Quimioter. 2022 Oct;35 Suppl 3(Suppl 3):20-24. doi: 10.37201/req/s03.05.2022. Epub 2022 Oct 24.

本文引用的文献

1
Epidemiology of Methicillin-Resistant Staphylococcus aureus Diabetic Foot Infections in a Large Academic Hospital: Implications for Antimicrobial Stewardship.大型学术医院耐甲氧西林金黄色葡萄球菌糖尿病足感染的流行病学:对抗菌药物管理的启示
PLoS One. 2016 Aug 24;11(8):e0161658. doi: 10.1371/journal.pone.0161658. eCollection 2016.
2
Risk factors for methicillin-resistant Staphylococcus aureus in diabetic foot infections.糖尿病足感染中耐甲氧西林金黄色葡萄球菌的危险因素。
Diabet Foot Ankle. 2014 Apr 10;5. doi: 10.3402/dfa.v5.23575. eCollection 2014.
3
A systematic review and meta-analysis of the effects of antibiotic consumption on antibiotic resistance.抗生素使用与抗生素耐药性关系的系统评价和荟萃分析。
BMC Infect Dis. 2014 Jan 9;14:13. doi: 10.1186/1471-2334-14-13.
4
Antibiotic therapy for the treatment of methicillin-resistant Staphylococcus aureus (MRSA) in non surgical wounds.用于治疗非手术伤口耐甲氧西林金黄色葡萄球菌(MRSA)感染的抗生素疗法。
Cochrane Database Syst Rev. 2013 Nov 18;2013(11):CD010427. doi: 10.1002/14651858.CD010427.pub2.
5
Risk factors and gene type for infections of MRSA in diabetic foot patients in Tianjin, China.中国天津糖尿病足患者耐甲氧西林金黄色葡萄球菌感染的危险因素及基因类型
Int J Low Extrem Wounds. 2013 Jun;12(2):106-12. doi: 10.1177/1534734613489991.
6
Gram-negative diabetic foot osteomyelitis: risk factors and clinical presentation.革兰氏阴性菌所致糖尿病足骨髓炎:危险因素及临床表现
Int J Low Extrem Wounds. 2013 Mar;12(1):63-8. doi: 10.1177/1534734613477423. Epub 2013 Feb 26.
7
2012 Infectious Diseases Society of America clinical practice guideline for the diagnosis and treatment of diabetic foot infections.2012 年美国传染病学会临床实践指南:糖尿病足感染的诊断与治疗。
Clin Infect Dis. 2012 Jun;54(12):e132-73. doi: 10.1093/cid/cis346.
8
[Risk factors for infections of methicillin-resistant Staphylococci in diabetic foot patients].[糖尿病足患者耐甲氧西林葡萄球菌感染的危险因素]
Zhonghua Yi Xue Za Zhi. 2012 Jan 31;92(4):228-31.
9
Study of plasmid-mediated extended-spectrum β-lactamase-producing strains of enterobacteriaceae, isolated from diabetic foot infections in a North Indian tertiary-care hospital.研究从印度北部一家三级保健医院的糖尿病足感染中分离出的质粒介导的产超广谱β-内酰胺酶的肠杆菌科菌株。
Diabetes Technol Ther. 2012 Apr;14(4):315-24. doi: 10.1089/dia.2011.0197. Epub 2012 Jan 6.
10
Differences in minor amputation rate in diabetic foot disease throughout Europe are in part explained by differences in disease severity at presentation.欧洲各国糖尿病足病小截肢率的差异部分可以解释为就诊时疾病严重程度的差异。
Diabet Med. 2011 Feb;28(2):199-205. doi: 10.1111/j.1464-5491.2010.03192.x.